Dabigatran Etexilate 12714-0150-10
- Manufacturer
- Boehringer Ingelheim Pharma Gmbh And Co. Kg
- Dosage Form
- Pellet
- Product Type
- Drug For Further Processing
- Marketing Start
- October 26, 2010
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dabigatran Etexilate | 20 mg/1 |
Selected Package
12714-0150-10Selected20 PELLET in 1 DRUM (12714-150-10)